In order to increase CAR-NK cells anti-tumor efficacy, several studies proposed to enrich CARs with certain domains associated with NK cell signaling such as NK-specific 2B4 and DNAX-activation proteins-10 or − 12 (DAP-10 or DAP-12) as co-stimulatory domains. Here, TYROBP is linked to neoplasm.